Results 231 to 240 of about 2,907,437 (262)
Some of the next articles are maybe not open access.

Assuring That Double-Blind Is Blind

American Journal of Psychiatry, 2010
Roy H. Perlis   +5 more
openaire   +3 more sources

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

The Lancet, 2019
H. Gerstein   +499 more
semanticscholar   +1 more source

Double‐Blind Trial of Carisoprodol

Developmental Medicine & Child Neurology, 1962
SUMMARYA double‐blind trial of the drug carisoprodol in athetoid children showed no overall statistical evidence of the value of the drug.There was some evidence of improvement compared with the placebo in occasional cases.The same finding was made in a similar double‐blind trial of carisoprodol in spastic children.RÉSUMÉAucune évidence statistique de ...
openaire   +3 more sources

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial.

The Lancet Oncology, 2009
A. Cheng   +20 more
semanticscholar   +1 more source

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

The Lancet, 2018
L. Kappos   +326 more
semanticscholar   +1 more source

Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

The Lancet, 2018
E. Thiele   +43 more
semanticscholar   +1 more source

Is a double-blind drug study really double blind?

Biological Psychiatry, 1994
U. Halbreich, B. Bernardis, J. Quak
openaire   +2 more sources

The blind and the double blind

British Homoeopathic journal, 1996
openaire   +2 more sources

Home - About - Disclaimer - Privacy